Skip to Content

JG 8121 (Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg)

Generic Name: cobicistat/darunavir/emtricitabine/tenofovir alafenamide

Pill with imprint JG 8121 is Yellow, Capsule-shape and has been identified as Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg. It is supplied by Janssen Pharmaceuticals, Inc..

Symtuza is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for JG 8121

Symtuza

Generic Name
cobicistat/darunavir/emtricitabine/tenofovir alafenamide
Imprint
JG 8121
Strength
cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg
Color
Yellow
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Janssen Pharmaceuticals, Inc.
National Drug Code (NDC)
59676-0800
Inactive Ingredients
silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, magnesium silicate, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.